![]() |
FDA delays ruling on Acorda's MS drug until Jan
I didn't see anything posted about this yet here!
FDA delays ruling on Fampridine-SR, a drug to improve walking ability from Acorda. Acorda said the FDA extended its review because it recently submitted new information on its risk evaluation strategy for the drug. http://news.moneycentral.msn.com/pro...22&id=10582834 |
All times are GMT -5. The time now is 09:57 AM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.